The hypothesis of the calcium paradox has its origin in experiments done in neurogenically stimulated rat and mouse vas deferentia. Some old studies reported that reduction of Ca 2+ entry by mild concentrations of verapamil, diltiazem or nifedipine elicited the surprising augmentation of vas deferens contractions. Recent reports have also found that nifedipine caused a paradoxical augmentation of the exocytotic release of catecholamine elicited by paired depolarising pulses in voltage-clamped bovine chromaffin cells. Because these drugs are blocking the L-subtype of VACCs (voltage-activated calcium channels), augmented contraction and exocytosis was an unexpected outcome. Recent experiments in neurogenically-stimulated rat vas deferens have found a more drastic potentiation of contractions with the association of verapamil and cAMP-enhancer compounds. Thus, the interaction between the signalling pathways mediated by Ca 2+ and cAMP could explain those unexpected findings and the so-called calcium paradox.
Introduction
serve as a messenger signal to couple the stimulus to muscle contraction or to neurosecretion, among other myriad physiological responses [1, 2] . A vast amount of experiments performed since the discovery of the role of Ca 2+ in the control of the heart beat [3] have set the dogma that in excitable cells, the enhanced Ca VACCs causes a diminution of those responses [4, 5] . Two observations, however, did not follow the expected outcomes from the concepts of the stimulus-contraction coupling process [6] and the stimulus-secretion coupling [7] . These concepts imply that enhanced Ca 2+ entry during cell depolarisation and the triggering of the contraction or secretion responses. However, near four decades ago verapamil at low concentrations was shown to unexpectedly augment the neurogenically mediated contractions of the rat vas deferens [8] . On the other hand, nifedipine was recently found to paradoxically augment the exocytotic release of catecholamine triggered by double-pulse depolarisations in voltage-clamped bovine adrenal medullary chromaffin cells [9] . How these two blockers of the L-subtype of VACCs can augment, instead of reducing the Ca 2+ -dependent responses of contraction and secretion? This review is aimed at trying to give a response to this question through the recently coined term of the "calcium paradox" [10] .
Paradoxical Effects of L Channel Blockers in the Vas Deferens
The motor activity of several smooth muscles including lung, gut, blood vessels and vas deferens is controlled by neurotransmitters released from postganglionic sympathetic nerve endings, particularly [11] .
Hence, some authors found that verapamil abolished the electrically-evoked neurogenic contractions of the vas deferens [12] [13] . In an earlier study, however, it was reported that verapamil blocked the neurogenically mediated contractions of the rat vas deferens, as expected; nevertheless, this study also reported that the lower concentrations of verapamil caused a surprising augmentation of those contractions [8] . This paradoxical effect was corroborated in 1981 by French and Scott [14] , also in the electrically stimulated rat vas deferens. Furthermore, six years later a third study reported that verapamil and diltiazem enhanced the purinergic-mediated neurogenic twitch response of the rat vas deferens; this effect was attributed to an agonist effect of verapamil on presynaptic L-type VACCs, thus enhancing Ca 2+ entry and ATP release [15] . Two years later a fourth study appeared showing that both, L-type VACC blockers and activator BAY K 8644 elicited similar augmentations of the neurogenic contractions of the mouse vas deferens; the authors did not provide an explanation for such paradoxical observation [16] . In a recent report from our laboratory, we could reproduce those earlier observations in the neurogenically-induced contractions of the rat vas deferens: At lower concentrations verapamil elicited a tiny augmentation, while at higher concentrations the VACC blocker caused full inhibition of the contractions [10] . The interesting finding was that as the high verapamil concentrations, various cAMP enhancers such as phosphodiesterase inhibitors rolipram and IBMX (isobutyl methyl xanthine) and AC (adenylyl cyclase) activator forskolin, depressed the neurogenic vas deferens contractions; however, in the presence of cAMP enhancers the lower concentrations of verapamil caused a drastic augmentation of the neurogenic contractions mediated by endogenously released ATP. The inhibition of AC by SQ 22536 attenuated the enhanced contractions, suggesting that an interaction Ca 2+ -cAMP could possibly explain the paradoxical effects of combined verapamil plus cAMP enhancers [10] . We will come back to this interaction later on.
Paradoxical Effects of L Channel Blockers in Adrenal Chromaffin Cells
As in vas deferentia, some paradoxical effects have also been recently reported to occur in adrenal chromaffin cells. For instance, in a study performed in voltage-clamped bovine chromaffin cells, the blockade of L channels with nifedipine transformed the exocytotic responses elicited by a double-pulse protocol, from depression to facilitation [9] . In an earlier study, it was shown that nifedipine suppressed the endocytotic response triggered by a long depolarising stimulus [17] . The explanation for the paradoxical effect of nifedipine could rest in the fact inhibition of rapid endocytosis triggered by Ca 2+ entry through L channels of bovine chromaffin cells (α 1D , Cav 1.3) could unmask a full exocytotic response. A second explanation may lay in the observation that Ca 2+ entry through L channels causes the inhibition of P/Q channels (α 1A , Cav 2.1) [18] that in bovine chromaffin cells greatly contribute to the control of the exocytotic release of catecholamines [19] . By blocking L channels, nifedipine could remove the Ca 2+ dependent inactivation of P/Q channels to enhance Ca 2+ entry through them, and thereby augmenting
exocytosis. An additional explanation for the nifedipine paradoxical effect in chromaffin cells [9] could be found in the context of the calcium paradox described in the vas deferens and in the interaction Ca 2+ -cAMP [10] .
In the light of the paradoxical effects of combined verapamil plus rolipram in the vas deferens, it could be possible to implicate cAMP also in the paradoxical effects of nifedipine in the secretory process of chromaffin cells. In fact, several reports have been published on the role of cAMP in the regulation of neurotransmitter release as well as in the postsynaptic actions of different neurotransmitters [11] . Additionally, the release of sympathetic transmitters is regulated both by Ca 2+ and cAMP [20] [21] [22] [23] .
Furthermore, cAMP has also been shown to regulate the release of catecholamine from chromaffin cells. Some studies have shown a correlation between an elevation of [cAMP] I and catecholamine release in bovine chromaffin cells stimulated with nicotine [24] , PACAP [25] , histamine [26] or VIP [27] ; this is also true for the PDE inhibitors rolipram or IBMX [28] [29] [30] .
To enhance secretion, cAMP may act at several targets including the VACCs of chromaffin cells, the regulation of the size of subplasmalemmal vesicle pools and/or the kinetics of the fusion pore during the last steps of exocytosis [28] . Concerning VACCs it is well established that the L-subtypes are the most sensitive to cAMP and PKA (protein kinase A) [31] [32] [33] . For example, in mouse chromaffin cells rolipram augments both [cAMP] I, L currents and secretion [34] . Also, rolipram increased the size of the RRP (ready-release-vesicle-pool) [35] by 75%, nearly doubled the membrane area of single vesicles in rat chromaffin cells [32] , and augmented the quantal size by 38% also in rat chromaffin cells [36] . Furthermore, the AC activator forskolin enhanced by 50%, and rolipram by 25% the quantal size of single vesicles in bovine chromaffin cells [28] . On the other hand, in mouse chromaffin cells, rolipram increased more the size of the RRP (47%) than the quantity of Ca 2+ penetrating the cell (16%); this suggests that about 30% of the increased secretion is Ca 2+ -independent and occurs down-stream of [Ca 2+ ] c elevation through L channels, most likely by affecting directly the secretory apparatus [34] . However, as in the vas deferens, an interaction between Ca 2+ and cAMP may also occur in chromaffin cells; evidence for such interaction is actually lacking. Whether the paradoxical effects of nifedipine could be explained in the context of the calcium paradox emanated from the vas deferens, deserves experimental attention.
Interactions between Ca 2+ and cAMP
The hypothesis for a functional interaction between the intracellular signalling pathways mediated by Ca 2+ or cAMP has been extensively studied in a myriad cell and tissue systems. Generally, this interaction results in synergistic effects on cell functions [20, [37] [38] [39] [41] . Not surprisingly, the form of regulation reported in most studies is that in which ACs are regulated by Ca 2+ influx through VACCs.
Calcium also regulates the activity of several PDEs, an issue that nevertheless has been studied to a lesser extent [42] . The specific function of PDEs and their interaction with Ca 2+ likely contribute to the generation of cAMP microdomains. This is described in detail in a recent study that examined the response of two PDE1 isoforms to Ca 2+ influx through SOCCs (store-operated calcium channels) [43] . Such interaction has also been demonstrated in pancreatic acini [44] , parotid acini [20] , blowfly salivary glands [23] , hepatocytes [21] , airway epithelial cells [22] , cardiac myocytes [45] , skeletal myocytes [46] , and neurons [47] . The interaction Ca 2+ -cAMP has been extensively studied at the calcium channels of the ER (endoplasmic reticulum) [48] [49] [50] . For example, phosphorylation by PKA increases the open probability of the IP3R1 (inositol-tris-phosphate receptor 1) at submaximal IP3 concentrations in parotid acinar cells [20, 51] , suggesting that such phosphorylation increases the affinity of IP3 for its IP3R. In line with this observation are some experiments showing that cAMP augments the IP3R-mediated release of Ca 2+ from the ER in AR4-2J cells [52] and in blowfly salivary glands [53] . From a physiological point of view, it is worth mentioning that the activation of cardiac β1 adrenergic receptors increases phosphorylation of cardiac RyR2 (ryanodine receptors 2) to enhance Ca 2+ release from the SR (sarcoplasmic reticulum), that results in stronger and faster contractions [54] . In addition, a large body of literature discusses the regulation of VACCs in various cell types through their phosphorylation by PKA, including chromaffin cells [55] . Conversely, the cAMP pathway significantly regulates the machinery responsible for the clearance of the [Ca 2+ ]c transients elicited by cell stimulation [56] . Most Ca 2+ clearance during cell stimulation and at the end of the stimulation period is mediated by the PMCA (plasma membrane Ca 2+ ATPase pump) and the plasmalemmal NCX (Na + /Ca 2+ exchanger) isoforms that are particularly active in cardiac myocytes, neurons and the kidney. The main exchanger isoform is NCX1 that has several splice variants [56, 57] . Various studies suggested that the cardiac NCX can be phosphorylated by PKA on sites located in the large intracellular loop, which increases its activity [57] .
A Calcium Paradox in the Context of Neurotransmission
We recently re-investigated the paradoxical effects of verapamil on the neurogenic contractions of the rat vas deferens, first reported by Kreye and Luth in 1975 [8] . Considering that drugs which increase cAMP levels classically have relaxant effects in smooth muscles mainly through the inhibition of phosphorylation of smooth muscle myosin, and that high concentrations of L-type VACC blockers inhibit sympathetic transmission, the result we obtained was clearly unexpected: the combination of these drugs produced a drastic potentiation of neurogenic contractions, instead of the expected inhibition (Fig.  1) . Based on this intriguing result we built up the "calcium paradox" hypothesis, trying to explain the enigma that existed in sympathetic transmission since 1975 ( Figs. 1 and 2 ).
As discussed above, it is amply documented that cAMP causes the relaxation of smooth muscle; this is also true for L-type VACC blockers. Thus, by using separately compounds that augment cAMP and VACC blockers, their predominant effect could be exerted directly in the smooth muscle (postsynaptic), causing its relaxation. However, at presynaptic level (secretory apparatus, Fig. 2 ), low concentrations of VACC blockers, as well as agents that produce increase of cAMP may have excitatory effects on neurotransmission and other cellular responses. The combination of these drugs caused a synergistic effect (cAMP and Ca 2+ interaction) at this level, so predominating the presynaptic effect, and thus enhancing transmitter release to increase muscle contraction (Fig. 2) . It seems now clear that the "calcium paradox" occurs when using low concentrations of VACC blockers ( [8, [14] [15] [16] 58] . We try to explain this fact in Fig. 2 where two components associated to L-type VACC blockers are shown: the component of channel (fast activity) and the component of signalling pathway (slow activity). At low blocker concentrations, it is plausible that the component of signalling pathways is stronger enough to overcome the effect of mild VACC inhibition. Also, in results from our lab performed in bovine adrenal chromaffin cells (secretory response activity) we clearly see this phenomenon: nifedipine enhances their secretory activity [9] . In addition, it is plausible that the biphasic effect of BAY K 8644 on neurogenic contraction (dose-dependent contraction and relaxation) [59] and secretion [60] could also be explained in the context of the "calcium paradox". At higher concentrations, the intensive influx of Ca 2+ promoted by BAY K 8644 may inhibit the constitutive activity of Ca 2+ and cAMP signalling pathways associated to L-type VACCs, thus reducing the secretory response mediated by Ca 2+ release from the ER (Fig. 2) . The concept of the complex cAMP-IP 3 R interaction as a "third messenger", which may mediate the synergistic action of Ca 2+ and cAMP signalling, is now emerging [61] . Recent data suggest that IRBIT [61] . Increases in cAMP levels may lead to dissociation of IRBIT from IP 3 receptors and its translocation to effector proteins located either at intracellular organelles and/or the plasma membrane; in this manner, IRBIT functions as a "third messenger" that transmits the information carried out by the second messengers cAMP and IP 3 . At the same time, IRBIT integrates and synergizes the activity of the cAMP and Ca 2+ signalling systems, providing a molecular mechanism for the synergistic action between them. We think this "idea" fits into the calcium paradox hypothesis; in fact, the release of ER Ca 2+ into the cytosol, triggered by verapamil plus rolipram in rat chromaffin cell slices, was blocked upon ER Ca 2+ depletion with thapsigargin [10] .
Furthermore, considering that this "calcium paradox" could also explain data from different biological systems [62, 63] , it is becoming apparent that the enigma of "the calcium paradox" in the context of neurotransmission and neurosecretion may be resolved through the interaction between Ca 2+ and cAMP. However, further work is needed to clarify this challenging hypothesis.
Potential Therapeutic Translation to the Clinic of the Calcium Paradox
Considering the model in which [cAMP] c stimulates Ca 2+ release from SER (Fig. 2) , it may be plausible the use of the phosphodiesterase inhibitor rolipram, which increases [cAMP] i [64, 65] , in combination with low doses of verapamil to potentiate neurotransmission for therapeutic purposes. Recently, an animal study suggests that chronic treatment with rolipram together with typical antidepressants may be successful in treating depression [66] . Otherwise, verapamil is extensively used in the clinic, for example, to reduce blood pressure, especially in combination with other drugs for treating angina or cardiac dysrhythmias [67] . We could also infer that a therapy involving the combination of rolipram and verapamil should be done carefully in depressive and hypertensive patients, considering the role of sympathetic transmission in regulating vascular tone by releasing neurotransmitters into the vasculature. Thus, combination of L-type VACC blockers and rolipram, which increases [cAMP] i , could be used to enhance neurotransmission and mitigate deleterious excess Ca 2+ influx, a condition seen in aging and neurodegenerative diseases [68] . These hypotheses need further investigation in experiments with animal models of disease as well as in clinical trials. Note that neurogenic contractions were decreased at the higher verapamil concentrations (A); however, 
Conclusions
This review indicates that an interaction between Ca 2+ and cAMP signaling pathway could be important in the fine regulation of transmitter release from nerve ending, and dysfunctions of this interaction could be involved in adverse effects of anti-hypertensive and anti-depressant drugs. In contrast, this interaction could be a novel strategy to enhance neurotransmission and mitigate deleterious excess Ca 2+ influx, a condition seen in aging and neurodegenerative diseases.
